Four with Medical School ties are among 12 University of Michigan faculty and staff members recognized by the American Association for the Advancement of Science (AAAS) as 2023 fellows in recognition of their extraordinary achievements.

A new urine-based test addresses a major problem in prostate cancer: how to separate the slow growing form of the disease unlikely to cause harm from more aggressive cancer that needs immediate treatment.

The FDA approved the use of a therapeutic device invented and developed at the University of Michigan for use in children with acute kidney injury and sepsis or a septic condition requiring continuous kidney replacement therapy.

Measles: 10 things to know about immunization and prevention

Focusing on the ‘tripledemic’ of RSV, flu and COVID-19 infections that occurred last year, their results underscore the importance of all types of hospital emergency departments being prepared to care for sick children, especially when health systems become strained.

Winter surges in infectious diseases can ruin holidays, but vaccination against COVID-19, flu, RSV, whooping cough and pneumonia can help.

Michigan Medicine researchers have found that growing bacteria on agar mixed with organs is an efficient and effective way to study infectious pathogens.

Research published from experts at Michigan Medicine, the University of Pittsburgh School of Medicine, and UPMC Children’s Hospital of Pittsburgh shows that children in daycare centers were not significant spreaders of COVID-19

A cost effectiveness analysis of the updated COVID-19 vaccine shows that it will save money in older adults and give good value for other adults.

Metabolism pathways make tumors sensitive or resistant to treatments. A collaborative group leverages these avenues to explore the growing foundation of new potential therapies

Michigan Medicine researchers looked into a drug in development to treat prostate cancer called proxalutamide, which works by blocking an enzyme called TMPRSS2 (transmembrane protease, serine 2) that is regulated by androgen receptors, as a potential therapeutic for COVID.

A study from clinicians and researchers at the University of Michigan Rogel Cancer Center reveals findings from over 800 clinical assays performed for kidney patients with MiTF family gene mutations.

There are 13 U-M graduate medical education programs ranked in the top 10 by Doximity.

An interview with Dr. Steven Kunkel on research at U-M Medical School.

Gene therapy for hemophilia B, a rare bleeding disorder, reinforces lower bleeding rates and improved outcomes.